Open Access
Tableau I
Patients 1à8.
| Patients | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Sexe/Âge | F/60 | F/37 | F/34 | F/44 | F/26 | F/70 | F/76 | H/58 |
|
|
||||||||
| Nombre de RAP | 36 | 1 | 1 | 1 | 1 | 2 | >6 | 2 |
|
|
||||||||
| Délai introduction ETS - RAP (mois) | 24 | 11 | 36 | 1,5 | 144 | 13 | 13 | 1,5 |
|
|
||||||||
| Délai perfusion ETS - RAP (min) | 25 | 120 | 30 | 20 | 230 | 240 | >180 | >60 |
|
|
||||||||
| Atteinte cutanée | - | + | + | - | - | + | + | + |
|
|
||||||||
| Atteinte respiratoire | + | - | + | + | + | + | - | - |
|
|
||||||||
| Atteintecardio-vasculaire | - | - | - | +£ | - | - | - | - |
|
|
||||||||
| Grade | I-II | I | I | III | II | I-II | I | I-II |
|
|
||||||||
| IgE anti-GAA | - | - | - | - | - | - | - | + |
|
|
||||||||
| IgG anti-GAA | +++ | - | - | Pos. | - | +++ | Pos. | + |
|
|
||||||||
| Tryptase | - | - | - | - | - | - | - | N/A |
|
|
||||||||
| Tests allergologiques cutanés | N/A | PT-IDR + | N/A | PT + IDR + | N/A | N/A | N/A | PT + IDR + |
|
|
||||||||
| Réintroduction de l’ETS | - | Prémed.Protocolepersonnalisé | Prémed.Protocolepersonnalisé | SWORD | SWORD | Désensibilisation | Prémed. | SWORD |
|
|
||||||||
| Délai de réintroduction (mois) | N/A | 18 | 31 | 24 | 2 | 0 | 0 | 60 |
|
|
||||||||
| Suivi (années) | § | 3,9 | 2,0 | 8,0 | 3,6 | 3,0 | 1,5 | 3,5 |
|
|
||||||||
| Motifsde l’arrêt définitifde l’ETS | RAP de sévérité croissante. Perdue de vue. | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.